Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Edoxaban in the secondary prevention of VTE

Publication ,  Other
Levy, JH; Hunt, BJ
Published in: Lancet Haematology
March 2016

Duke Scholars

Published In

Lancet Haematology

Publication Date

March 2016

Volume

3

Issue

5

Start / End Page

e208 / e209

Related Subject Headings

  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Levy, J. H., & Hunt, B. J. (2016). Edoxaban in the secondary prevention of VTE. Lancet Haematology.
Levy, J. H., and B. J. Hunt. “Edoxaban in the secondary prevention of VTE.” Lancet Haematology, March 2016.
Levy JH, Hunt BJ. Edoxaban in the secondary prevention of VTE. Vol. 3, Lancet Haematology. 2016. p. e208–9.
Levy, J. H., and B. J. Hunt. “Edoxaban in the secondary prevention of VTE.” Lancet Haematology, vol. 3, no. 5, Mar. 2016, pp. e208–09.
Levy JH, Hunt BJ. Edoxaban in the secondary prevention of VTE. Lancet Haematology. 2016. p. e208–e209.

Published In

Lancet Haematology

Publication Date

March 2016

Volume

3

Issue

5

Start / End Page

e208 / e209

Related Subject Headings

  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology